GT Biopharma, Inc. (GTBP): Form 8-K filed 2026-09-03
- Accepted by EDGAR
- 2026-09-03 11:45 ET
- Event date
- 2026-09-02
- Accession no.
- 0001493152-26-041333
- Original filing
- SEC EDGAR filing index
Items reported
- Item 3.03: Material Modifications to Rights of Security Holders
The rights of holders of a class of the company's securities were materially modified, for example by a charter amendment, a rights plan or a reverse stock split. - Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
The company amended its articles of incorporation or bylaws without a shareholder vote that was previously disclosed, or changed its fiscal year. - Item 8.01: Other Events
A voluntary disclosure of an event the company considers important to security holders that no other Item covers, such as a dividend declaration, a buyback program, litigation updates or product news. - Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | 8-K | form8-k.htm |
| EX-3.1 | EX-3.1 | ex3-1.htm |
| EX-3.2 | EX-3.2 | ex3-2.htm |
| EX-3.3 | EX-3.3 | ex3-3.htm |
| EX-3.4 | EX-3.4 | ex3-4.htm |
| EX-3.5 | EX-3.5 | ex3-5.htm |
| EX-3.6 | EX-3.6 | ex3-6.htm |
| EX-3.7 | EX-3.7 | ex3-7.htm |
| EX-3.8 | EX-3.8 | ex3-8.htm |
| EX-3.9 | EX-3.9 | ex3-9.htm |
| EX-3.10 | EX-3.10 | ex3-10.htm |
| EX-3.11 | EX-3.11 | ex3-11.htm |
| EX-3.12 | EX-3.12 | ex3-12.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.